$IMUC News Tesla gains after safety rating; Su
Post# of 102911
Posted On: 09/17/2014 10:00:29 AM
$IMUC News
Tesla gains after safety rating; Supernus surges 1:32 p.m. Dec. 24, 2013 - Wallace Witkowski
CalAmp, ImmunoCellular, Darden are stocks to watch 6:30 a.m. Dec. 24, 2013 - Wallace Witkowski
CalAmp drops, ImmunoCellular rises after hours 7:07 p.m. Dec. 23, 2013 - Wallace Witkowski
Stock futures edge up after retail, claims data 10:23 a.m. Dec. 12, 2013 - Victor Reklaitis
ImmunoCellular plunges 54% on cancer-drug news 8:11 a.m. Dec. 12, 2013 - Barbara Kollmeyer
Facebook shares jump on S&P 500 inclusion 7:50 p.m. Dec. 11, 2013 - Wallace Witkowski
ImmunoCellular shares fall 50% after study result 5:24 p.m. Dec. 11, 2013 - Wallace Witkowski
ImmunoCellular Therapeutics rises 8% in premarket 8:57 a.m. Jan. 3, 2013 - Steve Gelsi
ImmunoCellular prices offering at 13% discount 9:53 a.m. Oct. 18, 2012 - MarketWatch.com
Thursday’s biggest gaining and declining stocks 4:43 p.m. Sept. 6, 2012 - Greg Morcroft
Wednesday’s biggest gaining and declining stocks 4:53 p.m. Aug. 22, 2012 - MarketWatch
Tuesday’s top gaining and declining stocks 4:25 p.m. Aug. 21, 2012 - MarketWatch
Hot stocks to watch 7:29 a.m. Aug. 21, 2012 - MarketWatch.com
Stocks to watch Tuesday: Church & Dwight, Nordson 6:51 a.m. Aug. 21, 2012 - MarketWatch
Urban Outfitters shares rally after hours 6:23 p.m. Aug. 20, 2012 - Carla Mozee
ImmunoCellular Therapeutics CEO resigns 5:07 p.m. Aug. 20, 2012 - MarketWatch.com
Thursday’s biggest gaining and declining stocks 1:00 p.m. May 31, 2012 - MarketWatch
ImmunoCellular: Thoughts On Management's Plan To Move ICT-107 Into Phase 3 10:18 a.m. Sept. 9, 2014 - Seeking Alpha
10-Q: IMMUNOCELLULAR THERAPEUTICS, LTD. 3:18 p.m. Aug. 8, 2014 - Edgar Online - (EDG = 10Q, 10K)
ImmunoCellular Therapeutics' (IMUC) CEO Andrew Gengos on Q2 2014 Results - Earnings Call Transcript 9:13 p.m. Aug. 7, 2014 - Seeking Alpha
Why Immunotherapies Have Made DelMar's Lead Drug A Necessity In Brain Cancer 2:40 p.m. July 15, 2014 - Seeking Alpha
Positive Trends For ImmunoCellular Therapeutics 10:57 a.m. June 9, 2014 - Seeking Alpha
Twelve Analyst Stocks to Buy Under $10 With Huge Implied Upside 8:31 a.m. June 7, 2014 - 247WallSt.com
ImmunoCellular Plans To Move ICT-107 Forward Into Phase III Trials Based On New Sub-Group Analysis Presented At ASCO 10:41 a.m. June 2, 2014 - Seeking Alpha
ImmunoCellular Therapeutics: Potential Near-Term Upward Spike 10:24 a.m. May 20, 2014 - Seeking Alpha
ImmunoCellular Therapeutics, Ltd. (IMUC) Catches Eye: Stock Jumps 10.26% - Tale of the Tape 8:44 a.m. May 20, 2014 - Zacks.com
SEC Casting Wide Net in Galena Investigation 3:35 p.m. May 14, 2014 - TheStreet.com
10-Q: IMMUNOCELLULAR THERAPEUTICS, LTD. 4:03 p.m. May 9, 2014 - Edgar Online - (EDG = 10Q, 10K)
Refuting The Latest Negative Blog On Northwest Biotherapeutics 3:50 p.m. April 3, 2014 - Seeking Alpha
10-K: IMMUNOCELLULAR THERAPEUTICS, LTD. 3:41 p.m. March 14, 2014 - Edgar Online - (EDG = 10Q, 10K)
Strength Seen in ImmunoCellular Therapeutics, Ltd. (IMUC): Stock Soars 14.05% - Tale of the Tape 9:44 a.m. Feb. 26, 2014 - Zacks.com
ImmunoCellular +13.2%, wins orphan drug status for ICT-107 in the EU 12:15 p.m. Feb. 25, 2014 - Seeking Alpha
ImmunoCellular: Is Approval Enough? 11:48 a.m. Feb. 24, 2014 - Seeking Alpha
Northwest Is A Good Long-Term Bet 11:57 a.m. Feb. 14, 2014 - Seeking Alpha
Focus On Cancer Immunotherapy Results 4:41 a.m. Jan. 25, 2014 - Seeking Alpha
NeoStem’s AMR-001 Has Strong Chance of Success 1:02 p.m. Jan. 22, 2014 - Wall St. Cheat Sheet
Strength Seen in ImmunoCellular Therapeutics (IMUC): Stock Surges 18.4% - Tale of the Tape 9:44 a.m. Jan. 21, 2014 - Zacks.com
ImmunoCellular Therapeutics Receives Positive Regulatory Feedback on ICT-107 Supporting Advancement to Registrational Phase III Testing in Newly Diagnosed Glioblastoma 6:00 a.m. Today - PR Newswire - PRF
ImmunoCellular Therapeutics Announces Second Quarter 2014 Financial Results 4:05 p.m. Aug. 7, 2014 - PR Newswire - PRF
ImmunoCellular Therapeutics to Report Financial Results for the Second Quarter 2014 on August 7, 2014 4:01 p.m. July 29, 2014 - PR Newswire - PRF
Equities to Watch in the Health Care Sector -- ImmunoCellular Therapeutics, Aeterna Zentaris, Lexicon Pharma, BioDelivery Sciences Intl., and Jazz Pharma 8:40 a.m. July 23, 2014 - PR Newswire - PRF
Glioblastoma Multiforme Therapeutics in Major Developed Markets to 2020 4:55 p.m. July 15, 2014 - PR Newswire - PRF
Theralase's Cancer Technology Demonstrates Vaccine-Like Properties 8:04 a.m. June 16, 2014 - ACCESSWIRE
ImmunoCellular Therapeutics Presents Updated ICT-107 Phase II Data in Patients with Newly Diagnosed Glioblastoma at the 2014 ASCO Annual Meeting 7:30 a.m. June 1, 2014 - PR Newswire - PRF
Pre-Market Pulse on Top Gainers -- Research on Inovio Pharma, Novavax, FreeSeas, and ImmunoCellular Therapeutics 11:05 a.m. May 20, 2014 - PR Newswire - PRF
ImmunoCellular Therapeutics Announces First Quarter 2014 Financial Results 4:01 p.m. May 8, 2014 - PR Newswire - PRF
ImmunoCellular Therapeutics to Report Financial Results for the First Quarter 2014 on May 8, 2014 6:00 a.m. May 1, 2014 - PR Newswire - PRF
ImmunoCellular Therapeutics Announces ICT-107 Phase II Data Abstract Accepted for Oral Presentation at the 2014 ASCO Annual Meeting 4:00 p.m. April 21, 2014 - PR Newswire - PRF
Technical Notes on Top Gainers -- Research on Sequenom, ImmunoCellular Therapeutics, Intellicheck Mobilisa, and La Jolla Pharma 8:33 a.m. March 20, 2014 - PR Newswire - PRF
ImmunoCellular Therapeutics Announces Fourth Quarter and Full Year 2013 Financial Results 4:00 p.m. March 13, 2014 - PR Newswire - PRF
ImmunoCellular Therapeutics Announces Change to Meeting Date for Annual Meeting of Stockholders 4:15 p.m. March 11, 2014 - PR Newswire - PRF
ImmunoCellular Therapeutics to Report Financial Results for the Fourth Quarter and Full Year 2013 on March 13, 2014 7:00 a.m. March 4, 2014 - PR Newswire - PRF
ImmunoCellular Therapeutics to Present at ROTH Conference on March 11th 7:00 a.m. March 3, 2014 - PR Newswire - PRF
ImmunoCellular Therapeutics Receives Orphan Drug Status for ICT-107 in Glioblastoma in the European Union 7:00 a.m. Feb. 25, 2014 - PR Newswire - PRF
ImmunoCellular Therapeutics' Founder and Chief Scientific Officer, John Yu, MD, Presents at "Targeting Cancer Stem Cells" Symposium 5:00 p.m. Feb. 14, 2014 - PR Newswire - PRF
ImmunoCellular Therapeutics to Present at the BIO CEO & Investor Conference on February 10, 2014 7:00 a.m. Feb. 3, 2014 - PR Newswire - PRF
ImmunoCellular Therapeutics Provides Update on 2014 Corporate Strategies and Milestones 7:00 a.m. Jan. 13, 2014 - PR Newswire - PRF
Tesla gains after safety rating; Supernus surges 1:32 p.m. Dec. 24, 2013 - Wallace Witkowski
CalAmp, ImmunoCellular, Darden are stocks to watch 6:30 a.m. Dec. 24, 2013 - Wallace Witkowski
CalAmp drops, ImmunoCellular rises after hours 7:07 p.m. Dec. 23, 2013 - Wallace Witkowski
Stock futures edge up after retail, claims data 10:23 a.m. Dec. 12, 2013 - Victor Reklaitis
ImmunoCellular plunges 54% on cancer-drug news 8:11 a.m. Dec. 12, 2013 - Barbara Kollmeyer
Facebook shares jump on S&P 500 inclusion 7:50 p.m. Dec. 11, 2013 - Wallace Witkowski
ImmunoCellular shares fall 50% after study result 5:24 p.m. Dec. 11, 2013 - Wallace Witkowski
ImmunoCellular Therapeutics rises 8% in premarket 8:57 a.m. Jan. 3, 2013 - Steve Gelsi
ImmunoCellular prices offering at 13% discount 9:53 a.m. Oct. 18, 2012 - MarketWatch.com
Thursday’s biggest gaining and declining stocks 4:43 p.m. Sept. 6, 2012 - Greg Morcroft
Wednesday’s biggest gaining and declining stocks 4:53 p.m. Aug. 22, 2012 - MarketWatch
Tuesday’s top gaining and declining stocks 4:25 p.m. Aug. 21, 2012 - MarketWatch
Hot stocks to watch 7:29 a.m. Aug. 21, 2012 - MarketWatch.com
Stocks to watch Tuesday: Church & Dwight, Nordson 6:51 a.m. Aug. 21, 2012 - MarketWatch
Urban Outfitters shares rally after hours 6:23 p.m. Aug. 20, 2012 - Carla Mozee
ImmunoCellular Therapeutics CEO resigns 5:07 p.m. Aug. 20, 2012 - MarketWatch.com
Thursday’s biggest gaining and declining stocks 1:00 p.m. May 31, 2012 - MarketWatch
ImmunoCellular: Thoughts On Management's Plan To Move ICT-107 Into Phase 3 10:18 a.m. Sept. 9, 2014 - Seeking Alpha
10-Q: IMMUNOCELLULAR THERAPEUTICS, LTD. 3:18 p.m. Aug. 8, 2014 - Edgar Online - (EDG = 10Q, 10K)
ImmunoCellular Therapeutics' (IMUC) CEO Andrew Gengos on Q2 2014 Results - Earnings Call Transcript 9:13 p.m. Aug. 7, 2014 - Seeking Alpha
Why Immunotherapies Have Made DelMar's Lead Drug A Necessity In Brain Cancer 2:40 p.m. July 15, 2014 - Seeking Alpha
Positive Trends For ImmunoCellular Therapeutics 10:57 a.m. June 9, 2014 - Seeking Alpha
Twelve Analyst Stocks to Buy Under $10 With Huge Implied Upside 8:31 a.m. June 7, 2014 - 247WallSt.com
ImmunoCellular Plans To Move ICT-107 Forward Into Phase III Trials Based On New Sub-Group Analysis Presented At ASCO 10:41 a.m. June 2, 2014 - Seeking Alpha
ImmunoCellular Therapeutics: Potential Near-Term Upward Spike 10:24 a.m. May 20, 2014 - Seeking Alpha
ImmunoCellular Therapeutics, Ltd. (IMUC) Catches Eye: Stock Jumps 10.26% - Tale of the Tape 8:44 a.m. May 20, 2014 - Zacks.com
SEC Casting Wide Net in Galena Investigation 3:35 p.m. May 14, 2014 - TheStreet.com
10-Q: IMMUNOCELLULAR THERAPEUTICS, LTD. 4:03 p.m. May 9, 2014 - Edgar Online - (EDG = 10Q, 10K)
Refuting The Latest Negative Blog On Northwest Biotherapeutics 3:50 p.m. April 3, 2014 - Seeking Alpha
10-K: IMMUNOCELLULAR THERAPEUTICS, LTD. 3:41 p.m. March 14, 2014 - Edgar Online - (EDG = 10Q, 10K)
Strength Seen in ImmunoCellular Therapeutics, Ltd. (IMUC): Stock Soars 14.05% - Tale of the Tape 9:44 a.m. Feb. 26, 2014 - Zacks.com
ImmunoCellular +13.2%, wins orphan drug status for ICT-107 in the EU 12:15 p.m. Feb. 25, 2014 - Seeking Alpha
ImmunoCellular: Is Approval Enough? 11:48 a.m. Feb. 24, 2014 - Seeking Alpha
Northwest Is A Good Long-Term Bet 11:57 a.m. Feb. 14, 2014 - Seeking Alpha
Focus On Cancer Immunotherapy Results 4:41 a.m. Jan. 25, 2014 - Seeking Alpha
NeoStem’s AMR-001 Has Strong Chance of Success 1:02 p.m. Jan. 22, 2014 - Wall St. Cheat Sheet
Strength Seen in ImmunoCellular Therapeutics (IMUC): Stock Surges 18.4% - Tale of the Tape 9:44 a.m. Jan. 21, 2014 - Zacks.com
ImmunoCellular Therapeutics Receives Positive Regulatory Feedback on ICT-107 Supporting Advancement to Registrational Phase III Testing in Newly Diagnosed Glioblastoma 6:00 a.m. Today - PR Newswire - PRF
ImmunoCellular Therapeutics Announces Second Quarter 2014 Financial Results 4:05 p.m. Aug. 7, 2014 - PR Newswire - PRF
ImmunoCellular Therapeutics to Report Financial Results for the Second Quarter 2014 on August 7, 2014 4:01 p.m. July 29, 2014 - PR Newswire - PRF
Equities to Watch in the Health Care Sector -- ImmunoCellular Therapeutics, Aeterna Zentaris, Lexicon Pharma, BioDelivery Sciences Intl., and Jazz Pharma 8:40 a.m. July 23, 2014 - PR Newswire - PRF
Glioblastoma Multiforme Therapeutics in Major Developed Markets to 2020 4:55 p.m. July 15, 2014 - PR Newswire - PRF
Theralase's Cancer Technology Demonstrates Vaccine-Like Properties 8:04 a.m. June 16, 2014 - ACCESSWIRE
ImmunoCellular Therapeutics Presents Updated ICT-107 Phase II Data in Patients with Newly Diagnosed Glioblastoma at the 2014 ASCO Annual Meeting 7:30 a.m. June 1, 2014 - PR Newswire - PRF
Pre-Market Pulse on Top Gainers -- Research on Inovio Pharma, Novavax, FreeSeas, and ImmunoCellular Therapeutics 11:05 a.m. May 20, 2014 - PR Newswire - PRF
ImmunoCellular Therapeutics Announces First Quarter 2014 Financial Results 4:01 p.m. May 8, 2014 - PR Newswire - PRF
ImmunoCellular Therapeutics to Report Financial Results for the First Quarter 2014 on May 8, 2014 6:00 a.m. May 1, 2014 - PR Newswire - PRF
ImmunoCellular Therapeutics Announces ICT-107 Phase II Data Abstract Accepted for Oral Presentation at the 2014 ASCO Annual Meeting 4:00 p.m. April 21, 2014 - PR Newswire - PRF
Technical Notes on Top Gainers -- Research on Sequenom, ImmunoCellular Therapeutics, Intellicheck Mobilisa, and La Jolla Pharma 8:33 a.m. March 20, 2014 - PR Newswire - PRF
ImmunoCellular Therapeutics Announces Fourth Quarter and Full Year 2013 Financial Results 4:00 p.m. March 13, 2014 - PR Newswire - PRF
ImmunoCellular Therapeutics Announces Change to Meeting Date for Annual Meeting of Stockholders 4:15 p.m. March 11, 2014 - PR Newswire - PRF
ImmunoCellular Therapeutics to Report Financial Results for the Fourth Quarter and Full Year 2013 on March 13, 2014 7:00 a.m. March 4, 2014 - PR Newswire - PRF
ImmunoCellular Therapeutics to Present at ROTH Conference on March 11th 7:00 a.m. March 3, 2014 - PR Newswire - PRF
ImmunoCellular Therapeutics Receives Orphan Drug Status for ICT-107 in Glioblastoma in the European Union 7:00 a.m. Feb. 25, 2014 - PR Newswire - PRF
ImmunoCellular Therapeutics' Founder and Chief Scientific Officer, John Yu, MD, Presents at "Targeting Cancer Stem Cells" Symposium 5:00 p.m. Feb. 14, 2014 - PR Newswire - PRF
ImmunoCellular Therapeutics to Present at the BIO CEO & Investor Conference on February 10, 2014 7:00 a.m. Feb. 3, 2014 - PR Newswire - PRF
ImmunoCellular Therapeutics Provides Update on 2014 Corporate Strategies and Milestones 7:00 a.m. Jan. 13, 2014 - PR Newswire - PRF
(0)
(0)